FindTrial
Sign In

Dehydroepiandrosterone (DHEA)

DIETARY_SUPPLEMENT8 trials

Sponsors

University of Michigan, Boston Children's Hospital, University of Aarhus, Jed E. Rose, Mayo Clinic

Conditions

Adrenal InsufficiencyAndrogen; HypersecretionAnorexia NervosaDehydroepiandrosteroneEndocrine System DiseasesHyperandrogenismInsulin ResistancePolycystic Ovary Syndrome

Phase 2

Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention
CompletedNCT00189124
University of MichiganSystemic Lupus Erythematosus
Start: 2003-09-30End: 2006-07-31Updated: 2016-05-18
Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa
CompletedNCT00310791
Boston Children's HospitalAnorexia Nervosa
Start: 2004-04-30End: 2010-12-31Updated: 2018-04-11
The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers
CompletedNCT00900900
Jed E. RoseSubstance Withdrawal Syndrome
Start: 2009-07-31End: 2011-03-31Updated: 2012-09-21

Phase 3

Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.
RecruitingNCT07843927
Charite University, Berlin, GermanyTreatment Resistant Depression (TRD)
Start: 2026-06-22End: 2028-09-30Target: 320Updated: 2026-09-28

Unknown Phase

Six Months DHEA Treatment in Female Adrenal Failure
CompletedNCT00471900
University of AarhusAdrenal Insufficiency
Start: 2001-10-31End: 2003-02-28Updated: 2007-05-10
Effects of Androgen Administration on Inflammation in Normal Women
CompletedNCT01753037
Mayo ClinicHyperandrogenism
Start: 2006-12-31End: 2010-04-30Updated: 2013-11-18
Dehydroepiandrosterone Maintain Mitochondrial Quality of Cumulus Cells in Poor Ovarian Responders
CompletedNCT03438812
Kaohsiung Veterans General Hospital.Dehydroepiandrosterone, Poor Responders
Start: 2017-09-06End: 2019-12-31Updated: 2021-02-18
Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS)
NCT05263557
Royal College of Surgeons, IrelandAndrogen; Hypersecretion, Endocrine System Diseases, Insulin Resistance +1
Start: 2022-08-19End: 2024-12-31Target: 20Updated: 2023-07-25